Discovering whether a chick is male or female while it is still in the egg. Leiden biotech company In Ovo, a spin-off of Leiden University, has been given an investment of several million euros to further develop its unique test method. The founders – both Leiden alumni – Wouter Bruins and Wil Stutterheim are now set to market their successful prototype.
The major part of the investment of several millions of euros comes from Evonik, originally a German chemicals company, and the venture capital company Visvires New Protein. Rabobank Leiden-Katwijk has also contributed what is known as a Subordinated Innovation Investment. Leiden University, which has been closely involved with the company from its outset, is also investing in In Ovo’s further development. The company is a spin off of the Leiden Institute of Biology and now works closely with the Leiden Academic Centre for Drug Research (LACDR). Read More